Market Research Logo

The Global Blood Industry

The Global Blood Industry

Global sales of blood products grew to nearly $30.2 billion in 2014 from $28.7 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.9% from 2014 to 2019, totaling nearly $38.3 billion in 2019.

This report provides:

An overview of the structure and current market size of the global blood industry, including coverage of such segments as blood and plasma collection, blood and plasma processing, blood therapeutic products, plasma therapeutic products, and emerging trends and products.

Analyses of global market trends, with data from 2011 to 2014, and projections of CAGRs through 2019.

Government and regulatory controls.

The impact of diseases on the blood industry.

Comprehensive company profiles of major players in the industry.


This study encompasses the wide range of products and services that comprise the global blood industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other regions. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion. Excluded from consideration are the clinical blood tests for diseases and conditions not involved in managing blood and plasma products.

CHAPTER 1 Introduction
STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
OVERVIEW
MAJOR FINDINGS
SUMMARY TABLE GLOBAL SALES OF BLOOD PRODUCTS, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL SALES OF BLOOD PRODUCTS, 2011-2019 ($ MILLIONS)
CHAPTER 3 OVERVIEW
THE BLOOD INDUSTRY
BLOOD INDUSTRY TERMS AND ABBREVIATIONS[1]
HISTORY OF THE BLOOD INDUSTRY
TABLE 1 TIMELINE OF THE BLOOD INDUSTRY
BLOOD AND ITS COMPONENTS
TABLE 2 COMPOSITION OF BLOOD
PLASMA
CELLULAR ELEMENTS
Red and White Blood Cells
Platelets
IMMUNOGLOBULIN PRODUCTS
THE DANGERS OF TRANSFUSED BLOOD
RISKS ASSOCIATED WITH TRANSFUSION
National Healthcare Safety Network -Biovigilance Component
Hemovigilance Module Surveillance
Diseases Contracted from Blood Transfusions and Related Identification
Testing
TABLE 3 MAJOR DISEASES CONTRACTED FROM BLOOD
TRANSFUSIONS, U.S. ANALYSIS
HIV/AIDS
TABLE 4 CBER LICENSED HIV DONOR SCREENING TESTS (LAST UPDATED JULY 2014)
Hepatitis A
Hepatitis B
TABLE 5 CBER-LICENSED SCREENING TESTS FOR HEPATITIS B (LAST UPDATED JULY 2014)
Hepatitis C
TABLE 6 CBER-LICENSED SCREENING TESTS FOR HEPATITIS C (LAST UPDATED JULY 2014)
Hepatitis D
Hepatitis E
Human T-Cell Lymphotropic Virus-(HTLV-I, -II)
TABLE 7 CBER-LICENSED SCREENING TESTS FOR HTLV-I AND HTLV-II (LAST UPDATED JULY 2014)
Cytomegalovirus
TABLE 8 CBER-LICENSED SCREENING TESTS FOR CMV (LAST UPDATED JULY 2014)
West Nile Virus
TABLE 9 CBER LICENSED SCREENING TESTS FOR WEST NILE (LAST UPDATED JULY 2014)
"Mad Cow Disease"-Creutzfeldt-Jakob Disease (CJD)
Syphilis
Advances in Rapid Syphilis Detection
TABLE 10 CBER-APPROVED MANUFACTURERS FOR SYPHILIS TESTS (LAST UPDATED JULY 2014)
Chagas Disease
TABLE 11 CBER-LICENSED SCREENING TESTS FOR T. CRUZI (LAST UPDATED JULY 2014)
Chlamydia Trachomatis
TABLE 12 CBER-APPROVED MANUFACTURERS FOR CHLAMYDIA SCREENING TESTS (LAST UPDATED JULY 2014)
Neisseria Gonorrhea
TABLE 13 CBER-LICENSED SCREENING TESTS FOR GONORRHEA (LAST UPDATED JULY 2014)
EFFORTS TO CREATE A VIRUS-FREE BLOOD SUPPLY
Plasma Treatments
Trinitrobutyl Phosphate and Sodium Cholate
Methylene Blue-treated Plasma
Amatosalen HCL-Treated Plasma
Platelet Treatments
RBCs
NEGATIVE REACTIONS FROM BLOOD TRANSFUSIONS
BLOOD/PLASMA COMPONENT RISKS
CHAPTER 4 THE BLOOD MANAGEMENT SYSTEM: BLOOD COLLECTION, PROCESSING AND USE
BLOOD COLLECTION
TYPES OF BLOOD ESTABLISHMENTS AND BLOOD FACILITIES
Major Facilities
Auxiliary Facilities
Transfusion Services
ORGANIZATIONS COLLECTING BLOOD
TABLE 14 FDA-REGISTERED BLOOD ESTABLISHMENTS BY STATE¹ AND POSSESSION
For-Profit Blood Collection
Plasma Collection Centers
National Donor Deferral Registry
Nonprofit Blood Collection
American Red Cross
Community Blood Banks
Hospitals
Additional Blood Collection Sites
BLOOD DONATION DEMOGRAPHICS
Global Demographic Trends
TABLE 15 ESTIMATED WORLD POPULATION ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS)
FIGURE 1 ESTIMATED WORLD POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS)
TABLE 16 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015 (MILLIONS)
FIGURE 2 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND 2015 (MILLIONS)
U.S. DEMOGRAPHICS
TABLE 17 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050 (THOUSANDS)
FIGURE 3 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050 (THOUSANDS)
Gender, Age and Life Expectancy
TABLE 18 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000 AND 2020 (YEARS)
FIGURE 4 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000-2020 (YEARS)
EUROPEAN DEMOGRAPHICS
TABLE 19 EUROPE POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050 (THOUSANDS)
FIGURE 5 EUROPE POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050 (THOUSANDS)
ASIA-PACIFIC DEMOGRAPHICS
TABLE 20 ASIA-PACIFIC POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050 (THOUSANDS)
FIGURE 6 ASIA-PACIFIC POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050 (THOUSANDS)
Global Life Expectancy
TABLE 21 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013 (YEARS)
FIGURE 7 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013 (YEARS)
DONOR RECRUITMENT AND REGULATIONS
BLOOD SCREENING AND EVALUATION
METHODS FOR COLLECTING BLOOD FROM A DONOR
Manual Collection
Automated Collection
Plasmapheresis
Plateletpheresis
Leukopheresis
Red Blood Cell Apheresis
PLASMA COLLECTION
Commercial Nature of Plasmapheresis
Global Nature of the Plasma Industry
Plasma Fractionators
Distributors/Brokers
BLOOD TYPING AND TESTING FOR DISEASES
Blood Typing
TABLE 22 TESTS ROUTINELY PERFORMED ON BLOOD DONATIONS
TABLE 23 BLOOD TYPE ANTIGEN/ANTIBODY REACTIONS
Methods of Typing
Manual Blood Typing Methods
Slide/Tile Testing
Tube Testing
Microplate
Automated Blood Typing and Screening Methods
Blood Testing
Blood Storage
BLOOD PROCESSING
Preparation and Use of the Components
Red Blood Cell Components
Platelets
Plasma
BLOOD TRANSFUSIONS
Transfusion in the U.S.
Testing before Transfusion
Manual Crossmatch Techniques
Major Crossmatch
Minor Crossmatch
Antibody Screen
Coombs Test
TYPES OF TRANSFUSIONS
Whole Blood
Packed Red Blood Cells
Platelets
Leukocytes
Fresh Frozen Plasma (FFP)
TABLE 24 SELECTED USES OF FFP
Cryoprecipitate
Coagulation Factors
TABLE 25 LISTING OF BLOOD PRODUCTS FOR THERAPEUTIC USE
Immune Serum Globulin/IMIG/IGIV
Factor VIII
Factor IX and Factor IX Complex
Factor VIIa
Fibrin/Thrombin
Therapeutic Apheresis
Experimental Blood and Plasma Products
BLOOD MANAGEMENT ISSUES
AVAILABILITY ISSUES
BLOODLESS SURGERY
Bloodless Medicine and Surgery Hospital Directory
SAFETY ISSUES: RISK MANAGEMENT
TABLE 26 FACTORS TO REDUCE RISKS OF TRANSFUSION-ASSOCIATED
DISEASES
Better Donor Screening
Better Viral Screening Tests
Get More Repeat Donors
Develop Better Viral Inactivation Processes
Selective Use of Blood Derivative Products
BLOOD TRANSFUSION FATALITIES
TABLE 27 TRANSFUSION-RELATED FATALITIES BY COMPLICATION, FY2008 -FY2012
TABLE 28 FATALITIES NOT RELATED TO TRANSFUSION OR TRANSFUSION NOT RULED OUT, FY2008-FY2012
TABLE 29 POST-DONATION "NOT RULED OUT” FATALITY REPORTS BY DONATED PRODUCT, FY2008-FY2012
CHAPTER 5 REGULATION OF THE BLOOD BUSINESS
REGULATION OF THE U.S. BLOOD BUSINESS
TABLE 30 FEDERAL ORGANIZATIONS RESPONSIBLE FOR U.S. BLOOD
SAFETY
STATUTORY AUTHORITY OF THE FDA
Center for Biologics Evaluation and Research
Office of Regulatory Affairs (ORA)
Office of Biologics, the Division of Blood and Blood Products
TABLE 31 FDA AUTHORITY IN REGULATING BLOOD BANKING AND BLOOD PRODUCTS
THE MAJOR REGULATIONS AND POLICY MATTERS CONCERNING THE U.S.
BLOOD SUPPLY
The Clinical Laboratory Improvement Act of 1988 (CLIA)
The FDA'S Five Layers
Donor Screening
Blood Testing
Donor Deferral Lists
Quarantine
Problems and Deficiencies
The FDA Blood Action Plan
Team Biologics
Program Alignment Action Plan for Fiscal 2015
Fuel, Phone Excise Taxes
HOW REGULATIONS ARE IMPLEMENTED
Inspecting Blood Banks and Plasma Collection Facilities
TABLE 32 MAJOR AREAS OF CONCERN FOR INSPECTING BLOOD
FACILITIES
GUIDANCE FOR INDUSTRY RECOGNITION AND USE OF A STANDARD FOR THE UNIFORM LABELING OF BLOOD AND BLOOD COMPONENTS
OTHER ORGANIZATIONS INVOLVED IN BLOOD REGULATION
National Heart, Lung and Blood Institute (NHLBI)
Blood Diseases and Resources Program
Health Care Financing Administration (HCFA)
The Department of Defense
State Regulatory Agencies
VOLUNTARY REGULATION BY PROFESSIONAL AND TRADE ASSOCIATIONS
PPTA: Plasma Protein Therapeutics Association
America's Blood Centers (ABC)
THE EUROPEAN UNION (EU) BLOOD DIRECTIVE
The International Society for Blood Transfusion - ISBT 128
CHAPTER 6 THE GLOBAL BLOOD AND BLOOD PRODUCTS MARKET
OVERVIEW
DRIVING FORCES OF THE INDUSTRY
FIGURE 8 VARIABLES INFLUENCING THE DYNAMICS OF DEMAND FOR BLOOD FOR TRANSFUSION
MARKET SUMMARY
FIGURE 9 BLOOD MARKET COST AND PRICING ANALYSIS
PRICING OF BLOOD
TABLE 33 U.S. COST OF BLOOD COMPONENTS, ESTIMATED, THROUGH 2014 ($)
National Blood Exchange (NBE)
RBCs and Leukoreduced RBCs
Platelets
Random Donor Platelets
Fresh Frozen Plasma (FFP)
Cryoprecipitate
Washed Cells
Deglycerolized Cells
Granulocytes
Gamma-Irradiated Blood
PATTERNS OF TRANSFUSION PROCEDURES
Leukoreduction
Impact of Autologous Donations
Types of Autologous Transfusions
Risks of PABD
Procedure Codes for Blood Transfusions and Related Services
TABLE 34 U.S. BLOOD TRANSFUSION AND RELATED SERVICES
CODES
CHAPTER 7 BLOOD INDUSTRY ANALYSIS
GLOBAL MARKETS FOR WHOLE BLOOD COLLECTIONS
LOCAL EFFORTS AND IMPROVEMENTS
Africa
South Africa
Asia
China
India
Japan
Pakistan
Islamic Republic of Iran
Sri Lanka
Vietnam
Europe
Britain
France
Germany
Russia
Montenegro
Netherlands
Switzerland
Turkey
North America and Caribbean
Canada
Haiti
Oceana Region
Australia
New Zealand
Cook Islands
South America
Argentina
Bolivia
Brazil
U.S. BLOOD COLLECTION DATA
TABLE 35 U.S. BLOOD COLLECTION AND TRANSFUSION DATA, THROUGH 2019* (MILLION UNITS/PINTS)
FIGURE 10 U.S. BLOOD COLLECTION AND TRANSFUSION DATA, 2007-2019 (MILLION UNITS/PINTS)
GLOBAL MARKETS FOR SOURCE PLASMA COLLECTIONS
TABLE 36 ESTIMATED AND PROJECTED GLOBAL PLASMA COLLECTIONS AND VALUES, THROUGH 2019 ($ BILLIONS, MILLIONS ML)
FIGURE 11 ESTIMATED AND PROJECTED GLOBAL PLASMA COLLECTIONS MARKET VALUE, 2013-2019 ($ BILLIONS)
GLOBAL MARKETS FOR BLOOD THERAPEUTICS
TABLE 37 GLOBAL SALES OF PLASMA THERAPEUTICS*, THROUGH 2019 ($ MILLIONS)
FIGURE 12 GLOBAL SALES OF PLASMA THERAPEUTICS*, 2011-2019 ($ MILLIONS)
FIGURE 13 MARKET SHARE FOR PLASMA THERAPEUTIC SALES BY REGION, 2014 (%)
PLASMA AND PLASMA-DERIVED PRODUCTS
Plasma Therapeutic Products
TABLE 38 GLOBAL MARKET SIZE PLASMA THERAPEUTIC DERIVATIVES BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 14 GLOBAL MARKET SIZE PLASMA THERAPEUTIC DERIVATIVES BY TYPE, 2011-2019 ($ MILLIONS)
ALBUMIN AND PLASMA PROTEIN FRACTION (PPF)
Recombinant Human Albumin
Albumin Market Dynamics
TABLE 39 ALBUMIN AND PLASMA PROTEIN FRACTION (PPF)
PRODUCTS (%)
Albumin and PPF Market Size
TABLE 40 GLOBAL MARKET FOR ALBUMIN AND PPF, THROUGH 2019 ($ MILLIONS)
FIGURE 15 GLOBAL MARKET FOR ALBUMIN AND PPF, 2011-2019 ($ MILLIONS)
TABLE 41 GLOBAL MARKET FOR ALBUMIN AND PPF BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 16 GLOBAL MARKET FOR ALBUMIN AND PPF BY REGION, 2011-2019 ($ MILLIONS)
Albumin and PPF Market Trends
CLOTTING FACTORS
TABLE 42 EXAMPLES OF COMMON BLOOD CLOTTING FACTORS
Hemophilia
TABLE 43 GLOBAL AND U.S. HEMOPHILIA STATISTICS
Market Demand and Market Size
TABLE 44 GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS, THROUGH 2019 ($ MILLIONS)
FIGURE 17 GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS, 2011-2019 ($ MILLIONS)
FIGURE 18 GLOBAL MARKET SHARE OF CLOTTING FACTOR SALES BY HUMAN AND RECOMBINANT PRODUCTS, 2014 (%)
TABLE 45 GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 19 GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS BY REGION, 2011-2019 ($ MILLIONS)
Factor VIII
TABLE 46 APPROVED FACTOR VIII PRODUCTS
TABLE 47 GLOBAL MARKET SHARE FACTOR VIII COMPANIES, 2014 (%/$ MILLIONS)
FIGURE 20 GLOBAL MARKET SHARE OF FACTOR VIII COMPANIES, 2014 (%)
FIGURE 21 GLOBAL MARKET SHARE OF FACTOR VIII SALES BY HUMAN AND RECOMBINANT PRODUCTS, 2014 (%)
Factor IX
TABLE 48 APPROVED FACTOR IX PRODUCTS
TABLE 49 GLOBAL MARKET SHARE FACTOR IX COMPANIES, 2014 (%/$ MILLIONS)
FIGURE 22 GLOBAL MARKET SHARE OF FACTOR IX COMPANIES, 2014 (%)
FIGURE 23 GLOBAL MARKET SHARE OF FACTOR IX SALES BY HUMAN AND RECOMBINANT PRODUCTS, 2014 (%)
Factor VIIa
Biosimilar Factor VIIa Development
TABLE 50 APPROVED FACTOR VII PRODUCTS
TABLE 51 GLOBAL MARKET SHARE OF FACTOR IX COMPANIES, 2014 (%/$ MILLIONS)
FIGURE 24 GLOBAL MARKET SHARE OF FACTOR IX COMPANIES, 2014 (%)
Factor XIII
TABLE 52 APPROVED FACTOR XIII PRODUCTS
Prothrombin Complex Concentrates
TABLE 53 APPROVED PROTHROMBIN COMPLEX CONCENTRATE
PRODUCTS
IMMUNOGLOBULINS
IVIG
TABLE 54 SELECTED CONDITIONS TREATED BY IVIG
TABLE 55 APPROVED IMMUNOGLOBULINS
Hyperimmunes
TABLE 56 APPROVED HYPERIMMUNE IMMUNOGLOBULINS
Other
IMIG
IMMUNOGLOBULIN MARKET SIZE
TABLE 57 GLOBAL MARKET FOR IMMUNOGLOBULINS, THROUGH 2019 ($ MILLIONS)
FIGURE 25 GLOBAL MARKET FOR IMMUNOGLOBULINS, 2011-2019 ($ MILLIONS)
TABLE 58 GLOBAL MARKET FOR IMMUNOGLOBULINS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 26 GLOBAL MARKET FOR IMMUNOGLOBULINS BY REGION, 2011-2019 ($ MILLIONS)
Respiratory Syncytial Virus
Hepatitis B Immune Globulin
Alpha-1-Proteinase Inhibitor
Other Immunoglobulin Segments
CMV Immunoglobulin
Rabies Immunoglobulin
Rho(D) Immunoglobulin
Tetanus Immunoglobulin (TIG)
Vaccinia Immune Globulin Intravenous (VIG)
Varicella Immunoglobulin
TABLE 59 GLOBAL MARKET SHARE OF IMMUNOGLOBULIN COMPANIES, 2014
FIGURE 27 GLOBAL MARKET SHARE OF IMMUNOGLOBULIN COMPANIES, 2014 (%)
FIBRIN SEALANTS AND THROMBIN
TABLE 60 APPROVED FIBRIN SEALANTS AND FIBRIN PRODUCTS
Fibrin Sealants and Thrombin Market Size
TABLE 61 GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN, THROUGH 2019 ($ MILLIONS)
FIGURE 28 GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN, 2011- 2019 ($ MILLIONS)
TABLE 62 GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 29 GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN BY REGION, 2011-2019 ($ MILLIONS)
TABLE 63 GLOBAL MARKET SHARE OF FIBRIN SEALANTS AND THROMBIN PRODUCT COMPANIES, 2014 (%/$ MILLIONS)
FIGURE 30 GLOBAL MARKET SHARE OF FIBRIN SEALANTS AND THROMBIN PRODUCT COMPANIES, 2014 (%)
ANTITHROMBIN III
TABLE 64 APPROVED ANTITHROMBIN PRODUCTS
Antithrombin Market Size
TABLE 65 GLOBAL MARKET FOR ANTITHROMBIN, THROUGH 2019 ($ MILLIONS)
FIGURE 31 GLOBAL MARKET FOR ANTITHROMBIN, 2011-2019 ($ MILLIONS)
TABLE 66 GLOBAL MARKET FOR ANTITHROMBIN BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 32 GLOBAL MARKET FOR ANTITHROMBIN BY REGION, 2011-2019 ($ MILLIONS)
GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS
TABLE 67 GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 33 GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS BY REGION, 2011-2019 ($ MILLIONS)
FIGURE 34 MARKET SHARE FOR BLOOD TYPING AND SCREENING PRODUCT SALES BY REGION, 2014 (%)
TABLE 68 GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS, THROUGH 2019 ($ MILLIONS)
FIGURE 35 GLOBAL MARKET FOR BLOOD TYPING AND SCREENING PRODUCTS, 2011-2019 ($ MILLIONS)
SCREENING BLOOD
POLYMERASE CHAIN REACTION (PCR) AMPLIFICATION
TABLE 69 SELECTED PCR DONOR SCREENING TESTS
NUCLEIC ACID AMPLIFICATION TEST (NAAT)
TABLE 70 SELECTED NAT DONOR SCREENING TESTS
IMMUNOASSAY
TABLE 71 SELECTED IMMUNOASSAY DONOR SCREENING TESTS
MARKET SIZE OF BLOOD TESTING PRODUCTS FOR DONOR SCREENING
TABLE 72 GLOBAL BLOOD DONOR SCREENING TESTING MARKET BY TYPE OF TESTS, THROUGH 2019 ($ MILLIONS)
FIGURE 36 GLOBAL BLOOD DONOR SCREENING TESTING MARKET BY TYPE OF TEST, 2011- 2019 ($ MILLIONS)
BLOOD TYPING
TABLE 73 BLOOD GROUP AND RH TYPE AND COMPATIBLE BLOOD FOR TRANSFUSION
MARKET STRUCTURE AND PARTICIPANTS
Manual Typing Methods
Automated Blood Typing
Beckman Coulter
Immucor
Ortho Clinical Diagnostics
MARKET SIZE OF BLOOD TYPING
TABLE 74 GLOBAL BLOOD TYPING MARKET: INSTRUMENTS AND SUPPLIES BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 37 GLOBAL BLOOD TYPING MARKET: INSTRUMENTS AND SUPPLIES BY TYPE, 2011-2019 ($ MILLIONS)
GLOBAL MARKETS FOR BLOOD PROCESSING EQUIPMENT AND ASSOCIATED
PRODUCTS
TABLE 75 GLOBAL SALES OF BLOOD COLLECTION AND PROCESSING EQUIPMENT AND DISPOSABLES, THROUGH 2019 ($ MILLIONS)
FIGURE 38 GLOBAL SALES OF BLOOD COLLECTION AND PROCESSING EQUIPMENT AND DISPOSABLES, 2011-2019 ($ MILLIONS)
FIGURE 39 MARKET SHARE FOR BLOOD COLLECTION AND PROCESSING EQUIPMENT AND DISPOSABLE SALES BY REGION, 2014 (%)
TABLE 76 GLOBAL MARKET FOR BLOOD AND PLASMA COLLECTION/TRANSFUSION PRODUCTS, THROUGH 2019 ($ MILLIONS)
FIGURE 40 GLOBAL MARKET FOR BLOOD AND PLASMA COLLECTION/TRANSFUSION PRODUCTS, 2011-2019 ($ MILLIONS)
COLLECTION PRODUCTS
TABLE 77 GLOBAL MARKET FOR BLOOD COLLECTION PRODUCTS BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 41 GLOBAL MARKET FOR COLLECTION PRODUCTS BY TYPE, 2011-2019 ($ MILLIONS)
BLOOD AND PLASMA COLLECTION SUPPLIES
Plasma Collection Sets
Blood Bags
PLASMA AND BLOOD COLLECTION EQUIPMENT
Blood Salvage
Other Collection Equipment
MARKET PARTICIPANTS
Haemonetics
PCS2
Cymbal
MCS+ 8150 System
MCS+ 9000 System
Cell Saver Systems
OrthoPAT System
ACP 215 System
Fresenius Kabi (Fenwal Inc.)
Apheresis Collections
Autopheresis-C
Alyx Component Collection System
Amicus Separator
Aurora
Terumo BCT
TRANSFUSION PRODUCTS
TABLE 78 GLOBAL MARKET FOR TRANSFUSION PRODUCTS BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 42 GLOBAL MARKET FOR TRANSFUSION PRODUCTS BY TYPE, 2011-2019 ($ MILLIONS)
Transfusion Sets
Blood Filter Market
Transfusion Equipment
Accessories
CHAPTER 8 BLOOD RESEARCH AND DEVELOPMENT
DEDICATED BLOOD RESEARCH FACILITIES
JEROME H. HOLLAND LABORATORY (ARC)
NATIONAL BLOOD FOUNDATION (NBF)
STEM CELL RESEARCH
BLOOD SUBSTITUTES
RECOMBINANT DEVELOPMENT ACTIVITIES
NEW DEVELOPMENTS IN IMMUNOGLOBULINS
CSL BEHRING'S COMMITMENT TO CLOTTING FACTOR DEVELOPMENT
FIBRIN SEALANT AND GLUE DEVELOPMENTS
ALBUMIN AND IVIG TREATMENT FOR ALZHEIMER'S DISEASE
TABLE 79 CLINICAL TRIAL: ALBUMIN IN ALZHEIMER'S TREATMENT
INVESTIGATIONAL DEVICE TO HELP IMPROVE BLOOD SUPPLY SAFETY
THE VETERINARY BLOOD MARKET
TABLE 80 DOG AND CAT BLOOD TYPES AND DESCRIPTIONS
TABLE 81 REGIONAL VETERINARY BLOOD BANKS
CHAPTER 9 TECHNOLOGY
CLASSICAL FRACTIONATION METHODS
COHN FRACTIONATION
ADVANCED FRACTIONATION METHODS
AMPLIFICATION METHODS
POLYMERASE CHAIN REACTION (PCR)
NUCLEIC ACID AMPLIFICATION TECHNOLOGY (NAT)
IMMUNOASSAY
ENZYME IMMUNOASSAY (EIA)
Basic EIA
FIGURE 43 THE BASIC ENZYME IMMUNOASSAY (EIA) PROCESS
Alternate EIA Methods
Second-Antibody Precipitation Method
Double-Antibody Sandwich Method
Reverse-Sandwich Method
Reverse-Sandwich Inhibition Method
PATENT ANALYSIS
TABLE 82 RECENTLY ISSUED PATENTS
TABLE 83 PATENTS BY COUNTRY OF ORIGIN
TABLE 84 RECENT PATENTS BY ASSIGNEE
FRESENIUS MEDICAL CARE
ORTHO-CLINICAL DIAGNOSTICS INC.
ABBOTT LABORATORIES
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
AUBURN UNIVERSITY
CERNER INNOVATION INC.
CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES
FENWAL INC.
GELANUS B.V.
MICRONICS INC.
NEW YORK BLOOD CENTER INC.
TERUMO KABUSHIKI KAISHA
PATENT EXAMPLES
RECENT PATENTS
Blood Transfusions: Six Patents
Blood Bank: Three Patents
Blood Donor: Three Patents
CHAPTER 10 FDA LICENSED BLOOD ESTABLISHMENTS
GUIDANCE FOR INDUSTRY RECOGNITION AND USE OF A STANDARD FOR THE UNIFORM LABELING OF BLOOD AND BLOOD COMPONENTS
LABELING STANDARDS
REPORTING REQUIREMENTS FOR LICENSED ESTABLISHMENTS
FDA-LICENSED ESTABLISHMENTS
CHAPTER 11 COMPANY PROFILES
ABBOTT LABORATORIES
TABLE 85 ABBOTT'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 44 ABBOTT'S SALES HISTORY, 2012-2014* ($ MILLIONS)
ASTRAZENECA PLC
TABLE 86 ASTRAZENECA'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 45 ASTRAZENECA'S SALES HISTORY, 2012-2014* ($ MILLIONS)
BAXTER INTERNATIONAL INC.
TABLE 87 BAXTER'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 46 BAXTER'S SALES HISTORY, 2012-2014* ($ MILLIONS)
BAYER AG
TABLE 88 BAYER'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 47 BAYER'S SALES HISTORY, 2012-2014* ($ MILLIONS)
BIO-RAD LABORATORIES INC.
TABLE 89 BIO-RAD'S SALES HISTORY, 2012-2014* ($ THOUSANDS)
FIGURE 48 BIO-RAD'S SALES HISTORY, 2012-2014* ($ THOUSANDS)
CSL BEHRING
TABLE 90 CSL LIMITED'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 49 CSL LIMITED'S SALES HISTORY, 2012-2014* ($ MILLIONS)
ENTEGRION INC.
GRIFOLS INTERNATIONAL, S.A./TALECRIS
TABLE 91 GRIFOLS' SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 50 GRIFOLS' SALES HISTORY, 2012-2014* ($ MILLIONS)
HAEMONETICS CORP.
TABLE 92 HAEMONETICS' SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 51 HAEMONETICS' SALES HISTORY, 2012-2014* ($ MILLIONS)
HOLOGIC INC.
TABLE 93 HOLOGIC'S SALES HISTORY, 2012-2014 ($ MILLIONS)
FIGURE 52 HOLOGIC'S SALES HISTORY, 2012-2014 ($ MILLIONS)
LFB GROUP
TABLE 94 LFB GROUP'S SALES HISTORY, 2012-2013 ($ MILLIONS)
FIGURE 53 LFB GROUP'S SALES HISTORY, 2012-2013 ($ MILLIONS)
NOVO NORDISK A/S
TABLE 95 NOVO NORDISK'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 54 NOVO NORDISK'S SALES HISTORY, 2012-2014* ($ MILLIONS)
OCTAPHARMA AG
TABLE 96 OCTAPHARMA'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 55 OCTAPHARMA'S SALES HISTORY 2012-2014* ($ MILLIONS)
PFIZER INC.
TABLE 97 PFIZER'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 56 PFIZER'S SALES HISTORY, 2012-2014* ($ MILLIONS)
ROCHE HOLDING LTD.
TABLE 98 ROCHE'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 57 ROCHE'S SALES HISTORY, 2012-2014* ($ MILLIONS)
SANOFI S/A
TABLE 99 SANOFI'S SALES HISTORY, 2012-2014* ($ MILLIONS)
FIGURE 58 SANOFI'S SALES HISTORY, 2012-2014* ($ MILLIONS)
CHAPTER 12 APPENDIX: MAJOR SOURCES OF INFORMATION
COMPANIES
ABAXIS INC.
ABBOTT LABORATORIES
ALBUMIN BIOSCIENCE
ALERE INC.
ALFA SCIENTIFIC DESIGNS INC.
AMERICAN RED CROSS
ARKRAY INC.
ARYOGEN BIOPHARMA CO.
ASTRAZENECA PLC
AVIOQ INC.
BAXTER INTERNATIONAL INC.
BAYER AG
BECKMAN COULTER INC.
BECTON, DICKINSON, & CO.
BIOGEN IDEC
BIOMERIEUX FRANCE
BIO PRODUCTS LABORATORY LTD.
BIO-RAD LABORATORIES INC.
BIOTEST AG
BRISTOL-MYERS SQUIBB CO.
BTG INTERNATIONAL
BTNX INC.
CANGENE CORP. (SEE EMERGENT BIOSOLUTIONS)
CHARTER MEDICAL LTD.
CHURCH & DWIGHT CO. INC.
CSL BEHRING
DANAHER CORP.
EMERGENT BIOSOLUTIONS
ENTEGRION INC.
FORA CARE INC.
FRESENIUS KABI AG
FUJIREBIO DIAGNOSTICS INC.
GAMBRO INC.
G.E. HEALTHCARE LTD.
GLAXOSMITHKLINE PLC
GRIFOLS INTERNATIONAL, S.A.
HAEMONETICS CORP.
HAEMOTRONIC S.P.A.
HEMACARE CORP.
HEMOCUE AB
HOLOGIC INC.
IMMUCOR INC.
INTERNATIONAL TECHNIDYNE CORP.
JANT PHARMACAL CORP.
JOHNSON & JOHNSON
KEDRION S.P.A
LFB GROUP
MERIDIAN BIOSCIENCE INC.
NATIONAL GENETICS INSTITUTE
NEXTRON MEDICAL TECHNOLOGIES
NIPRO DIAGNOSTICS INC.
NOVA BIOMEDICAL CORP.
NOVARTIS AG
NOVO NORDISK A/S
NOVOZYMES BIOPHARMA DK A/S
OCTAPHARMA AG
OMRIX BIOPHARMACEUTICALS LTD. (SEE JOHNSON & JOHNSON)
ORASURE TECHNOLOGIES INC.
ORTHO CLINICAL DIAGNOSTICS INC.
PALL CORP.
PFIZER INC.
PHAMATECH INC.
PRINCETON BIOMEDITECH CORP.
QIAGEN N.V.
QUEST DIAGNOSTICS
QUIDEL CORP.
RESPONSE BIOMEDICAL CORP.
REVO BIOLOGICS
ROCHE HOLDING LTD.
SANOFI S/A
SANQUIN BLOOD SUPPLY
SA SCIENTIFIC LTD.
SEKISUI DIAGNOSTICS
SIEMENS MEDICAL SOLUTIONS
SPECTRAL DIAGNOSTICS
STANBIO LABORATORY
TAKEDA PHARMACEUTICAL CO. LTD.
TERUMO BCT
TRINITY BIOTECH PLC
ZEUS SCIENTIFIC INC.
GLOBAL BLOOD DONATION SOURCES
AMERICAN ASSOCIATION OF BLOOD BANKS
AMERICAN FRIENDS OF MAGEN DAVID ADOM
ARMED SERVICES BLOOD PROGRAM
ASSOCIATION OF VOLUNTARY ITALIAN BLOOD DONORS
AUSTRALIAN RED CROSS
CANADIAN BLOOD SERVICES
HEARTLAND BLOOD CENTERS
HONG KONG RED CROSS
INDIAN RED CROSS SOCIETY
IRISH NATIONAL BLOOD CENTRE
JAPANESE RED CROSS SOCIETY
NATIONAL BLOOD SERVICE
NEW ZEALAND BLOOD SERVICE
SOUTH AFRICAN NATIONAL BLOOD SERVICE
WORLD HEALTH ORGANIZATION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report